University of North Carolina at Chapel Hill, Department of Pediatric Gastroenterology, Chapel Hill, North Carolina, USA.
Duke University Population Health Sciences, Durham, North Carolina, USA.
Inflamm Bowel Dis. 2021 Feb 16;27(3):344-351. doi: 10.1093/ibd/izaa083.
PROMIS Pediatric domains provide self-reported measures of physical, emotional, and social health in children with chronic conditions. We evaluated the responsiveness of the PROMIS Pediatric measures to changes in disease activity and disease-specific, health-related quality of life (HRQOL) in children with Crohn's disease (CD).
IBD Partners Kids & Teens is an internet-based cohort of children with inflammatory bowel disease (IBD). Participants age 9 to 17 report symptoms related to disease activity (short Crohn's Disease Activity Index [sCDAI]), the IMPACT-III HRQOL measure, and 5 PROMIS Pediatric domains. We conducted longitudinal analyses using mixed linear models to examine the extent to which PROMIS Pediatric measures respond to changes in sCDAI and IMPACT-III.
Our study sample included 544 participants with CD (mean age 13 years, 44% female). All PROMIS Pediatric domains responded to changes in sCDAI, indicating improved physical, emotional, and social health, corresponding to improved disease activity and the converse (P < 0.001). Observed effect estimates ranged from 1.8 for peer relationships to 6.8 for fatigue. Of 246 participants with 2 or more completed reports, disease activity was stable in 527, worse in 72, and improved in 67. Changes in PROMIS Pediatric scores were associated with changes in IMPACT-III (r = -0.43 for anxiety, r = -0.45 for depressive symptoms, r = -0.43 for pain interference, r = -0.59 for fatigue, and r = 0.23 for peer relationships).
This study provides evidence for the longitudinal responsiveness of the PROMIS Pediatric measures to change in disease status and HRQOL in pediatric CD patients.
PROMIS 儿科领域为患有慢性疾病的儿童提供了身体、情感和社会健康的自我报告测量。我们评估了 PROMIS 儿科测量在儿童克罗恩病 (CD) 患者疾病活动度和疾病特异性健康相关生活质量 (HRQOL)变化中的反应能力。
IBD Partners Kids & Teens 是一个基于互联网的炎症性肠病 (IBD) 儿童队列。参与者年龄在 9 至 17 岁之间,报告与疾病活动相关的症状(短克罗恩病活动指数 [sCDAI])、IMPACT-III HRQOL 测量和 5 个 PROMIS 儿科领域。我们使用混合线性模型进行纵向分析,以检查 PROMIS 儿科测量在 sCDAI 和 IMPACT-III 变化中的反应程度。
我们的研究样本包括 544 名 CD 患者(平均年龄 13 岁,44%为女性)。所有 PROMIS 儿科领域都对 sCDAI 的变化做出反应,表明身体、情感和社会健康状况得到改善,对应于疾病活动度的改善和相反(P < 0.001)。观察到的效应估计值从同伴关系的 1.8 到疲劳的 6.8 不等。在 246 名有 2 次或更多次完成报告的参与者中,527 名患者的疾病活动稳定,72 名患者的疾病活动恶化,67 名患者的疾病活动改善。PROMIS 儿科评分的变化与 IMPACT-III 的变化相关(焦虑的 r = -0.43,抑郁症状的 r = -0.45,疼痛干扰的 r = -0.43,疲劳的 r = -0.59,同伴关系的 r = 0.23)。
本研究为 PROMIS 儿科测量在儿童 CD 患者疾病状态和 HRQOL 变化中的纵向反应能力提供了证据。